Records 1-5 (of 5 Records) |
Query Trace: ERBB2[original query]>>ERBB2[Gene] |
---|
Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19. Vastrad Basavaraj, et al. Gene reports 2020 12 0. 100956 ![]() ![]() ![]() |
Risk-adapted adjuvant therapy of luminal early breast cancer in 2020. Harbeck Nadia, et al. Current opinion in obstetrics & gynecology 2020 12 0. ![]() |
Management of early breast cancer during the COVID-19 pandemic in Brazil. Cavalcante Francisco Pimentel, et al. Breast cancer research and treatment 2020 8 0. ![]() |
Virus-CKB: an integrated bioinformatics platform and analysis resource for COVID-19 research. Feng Zhiwei, et al. Briefings in bioinformatics 2020 7 0. ![]() ![]() |
Molecular characterization of breast cancer needle core biopsy specimens by the 21-gene Breast Recurrence Score test. Jakubowski Debbie M, et al. Journal of surgical oncology 2020 6 0. ![]() |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 09, 2023
- Content source: